According to the latest report by IMARC Group, titled "Acalculous Cholecystitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033," the global acalculous cholecystitis market size is witnessing steady growth. Acalculous cholecystitis refers to a severe necroinflammatory disease that generally affects the gallbladder. It results from gallbladder ischemia and stasis that cause an inflammatory response in the gallbladder wall. It is a hypokinetic condition of the gallbladder that can be a life-threatening disorder, which has a high risk of necrosis and perforation compared to the other typical calculous disease. Some of the major factors responsible for the occurrence of acalculous cholecystitis include long periods of fasting, drastic weight loss and total parenteral nutrition (TPN) that causes a lack of gallbladder stimulation leading to a rise in the concentration of the bile salts within the organ. Besides this, it can also result from hormone-related issues and decreased nerve innervation from conditions, such as diabetes.
Global Acalculous Cholecystitis Market Trends:
The global market is primarily driven by the growing prevalence of gallbladder injury among the masses. Along with this, the rising awareness among individuals regarding the fatal impact of acalculous cholecystitis is providing a boost to the market. In addition to this, the escalating spending on the introduction of novel treatments options and drug development is creating a positive market outlook. Apart from this, the rising investments by public and private agencies to upgrade the overall healthcare infrastructure and the development of smooth supply distribution channels are significantly supporting the market on the global level. Moreover, continual technological advancements and the integration of the internet of things (IoT), sensors and machine learning (ML) with medical equipment are considered to be major driving factors. Other factors, rapid digitization, the penetration of high-speed internet connectivity and smartphones, the increasing number of clinical trials, continual modernization of medical equipment in the healthcare sector, the easy accessibility to numerous medical facilities across rural and geographically extended locations and the growing geriatric population, are also positively influencing the market.
- On the basis of the region, the market has been categorized into the United States, Germany, France, the United Kingdom, Italy, Spain and Japan.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for acalculous cholecystitis.
- The study also offers a thorough overview of the treatment practices for acalculous cholecystitis, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800